[APLS] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
05-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -52.55%
YoY- 59.04%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 176,571 99,182 22,056 5,650 646 0 0 -
PBT -56,853 -140,004 -190,823 -195,571 -135,700 -69,825 -35,972 7.91%
Tax 592 233 446 2,165 9,483 540 -281 -
NP -57,445 -140,237 -191,269 -195,571 -135,700 -69,825 -35,972 8.10%
Tax Rate - - - - - - - -
Total Cost 234,016 239,419 213,325 201,221 136,346 69,825 35,972 36.59%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -32.53 -141.39 -867.20 -3,461.43 -21,006.19 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.46 -1.17 -1.75 -2.28 -1.79 -1.10 -0.64 -5.35%
EPS Diluted -0.46 -1.17 -1.75 -2.28 -1.79 -1.10 -0.64 -5.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.